Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash-to-Debt No Debt
UTMD's Cash-to-Debt is ranked higher than
98% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. UTMD: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
UTMD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 10.16 Max: No Debt
Current: No Debt
Equity-to-Asset 0.88
UTMD's Equity-to-Asset is ranked higher than
95% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. UTMD: 0.88 )
Ranked among companies with meaningful Equity-to-Asset only.
UTMD' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.42  Med: 0.83 Max: 0.92
Current: 0.88
0.42
0.92
Interest Coverage No Debt
UTMD's Interest Coverage is ranked higher than
97% of the 133 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 45.06 vs. UTMD: No Debt )
Ranked among companies with meaningful Interest Coverage only.
UTMD' s Interest Coverage Range Over the Past 10 Years
Min: 13.79  Med: 54.27 Max: No Debt
Current: No Debt
Piotroski F-Score: 7
Altman Z-Score: 17.75
Beneish M-Score: -2.79
WACC vs ROIC
5.89%
29.15%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 42.29
UTMD's Operating Margin % is ranked higher than
99% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.86 vs. UTMD: 42.29 )
Ranked among companies with meaningful Operating Margin % only.
UTMD' s Operating Margin % Range Over the Past 10 Years
Min: 31.28  Med: 37.01 Max: 42.29
Current: 42.29
31.28
42.29
Net Margin % 31.71
UTMD's Net Margin % is ranked higher than
97% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.79 vs. UTMD: 31.71 )
Ranked among companies with meaningful Net Margin % only.
UTMD' s Net Margin % Range Over the Past 10 Years
Min: 19.58  Med: 26.75 Max: 31.71
Current: 31.71
19.58
31.71
ROE % 17.42
UTMD's ROE % is ranked higher than
83% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.30 vs. UTMD: 17.42 )
Ranked among companies with meaningful ROE % only.
UTMD' s ROE % Range Over the Past 10 Years
Min: 15.87  Med: 18.53 Max: 22.17
Current: 17.42
15.87
22.17
ROA % 15.34
UTMD's ROA % is ranked higher than
92% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.23 vs. UTMD: 15.34 )
Ranked among companies with meaningful ROA % only.
UTMD' s ROA % Range Over the Past 10 Years
Min: 12.61  Med: 14.64 Max: 17.53
Current: 15.34
12.61
17.53
ROC (Joel Greenblatt) % 128.47
UTMD's ROC (Joel Greenblatt) % is ranked higher than
99% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.88 vs. UTMD: 128.47 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
UTMD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 66.45  Med: 98.75 Max: 128.47
Current: 128.47
66.45
128.47
3-Year Revenue Growth Rate -0.90
UTMD's 3-Year Revenue Growth Rate is ranked lower than
67% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. UTMD: -0.90 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
UTMD' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -8.8  Med: 8.3 Max: 39.3
Current: -0.9
-8.8
39.3
3-Year EBITDA Growth Rate 2.10
UTMD's 3-Year EBITDA Growth Rate is ranked lower than
60% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.80 vs. UTMD: 2.10 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
UTMD' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -8.6  Med: 10.6 Max: 67
Current: 2.1
-8.6
67
3-Year EPS without NRI Growth Rate 2.20
UTMD's 3-Year EPS without NRI Growth Rate is ranked lower than
54% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. UTMD: 2.20 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
UTMD' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -10.4  Med: 13.9 Max: 109.9
Current: 2.2
-10.4
109.9
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» UTMD's 30-Y Financials

Financials (Next Earnings Date: 2017-07-26 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

UTMD Guru Trades in Q2 2016

Jim Simons 130,500 sh (+5.47%)
Chuck Royce 38,100 sh (unchged)
Charles Brandes Sold Out
» More
Q3 2016

UTMD Guru Trades in Q3 2016

Jim Simons 135,000 sh (+3.45%)
Chuck Royce 36,200 sh (-4.99%)
» More
Q4 2016

UTMD Guru Trades in Q4 2016

Jim Simons 137,000 sh (+1.48%)
Chuck Royce 36,200 sh (unchged)
» More
Q1 2017

UTMD Guru Trades in Q1 2017

Jim Simons 144,700 sh (+5.62%)
Chuck Royce 36,200 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with UTMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:NAS:CFMS, NAS:ENTL, NAS:SIEN, NAS:IVTY, NAS:ELGX, NAS:PLSE, NAS:MBOT, NAS:HBIO, AMEX:TRXC, NAS:BIOL, NAS:STAA, NAS:LAKE, NAS:ATRS, AMEX:BVX, NAS:LENS, AMEX:CRHM, NAS:EKSO, AMEX:MLSS, AMEX:RVP, NAS:VLRX » details
Headquarter Location:USA
Utah Medical Products Inc is in the business of producing medical devices that are predominantly proprietary, disposable and for hospital use.

Utah Medical Products Inc was formed as a Utah corporation in 1978. The Company is in the business of producing medical devices that are predominantly proprietary, disposable and for hospital use. The Company's products include those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians' offices. Products are sold in both domestic U.S. and international markets. The Company with particular interest in healthcare for women and their babies, develops, manufactures, assembles and markets disposable and reusable specialty medical devices designed for health outcomes for patients and their care-providers. It produces medical devices for Blood Pressure Monitoring and Blood Collection, Electrosurgery, Gynecology, Neonatal Critical Care, Perinatology and Urology. The Company's VAD Systems includes CMI patented soft silicone bell-shaped birthing cups and patented hand-held vacuum pumps. AROM-COT is a finger cover with a patented prong design to rupture maternal membranes with less patient pain and anxiety. The DISPOSA-HOOD is an infant respiratory hood that is used in the NICU to administer oxygen to neonates and flush CO2 while maintaining a neutral thermal environment critical to proper physiologic responses. The Company's DELTRAN blood pressure monitoring system has been adapted specifically for use in the Neonatal intensive care unit. The streamlined version eliminates needles used for blood sampling, avoids the loss of scarce neonatal blood volume and provides a closed system that reduces the risk of infection. The LETZ System (loop excision of the transformation zone) is used to excise cervical intraepithelial neoplasia (CIN) and other lower genital tract lesions related to human papilloma virus (HPV) infections. The Company's LETZ System includes patented disposable electrodes, the patented FINESSE electrosurgical generator, and other miscellaneous components. EPITOME is a patented electrosurgical scalpel which delivers precise performance in incision and excision with hemostasis while minimizing thermal side effects. LIBERTY is a device for the conservative treatment and effective control of urinary incontinence in women. LIBERTY is the easiest-to-use, cost effective incontinence treatment available that yields a therapeutic effect, not just a cover-up. LIBERTY consists of a battery operated electrical stimulation unit and an intravaginal electrode probe. In pressure monitoring, a transducer is used to convert physiological (mechanical) pressure into an electrical signal that is displayed on electronic monitoring equipment. It developed, patented and is now distributing its disposable transducer as a stand-alone product, and as a component in sterile blood pressure monitoring kits through direct representatives and other medical companies in the U.S., as well as independent distributors and other medical device companies internationally. The Company's products

Ratios

vs
industry
vs
history
PE Ratio 19.93
UTMD's PE Ratio is ranked higher than
75% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.48 vs. UTMD: 19.93 )
Ranked among companies with meaningful PE Ratio only.
UTMD' s PE Ratio Range Over the Past 10 Years
Min: 11.28  Med: 16.4 Max: 22.59
Current: 19.93
11.28
22.59
PE Ratio without NRI 19.93
UTMD's PE Ratio without NRI is ranked higher than
76% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.38 vs. UTMD: 19.93 )
Ranked among companies with meaningful PE Ratio without NRI only.
UTMD' s PE Ratio without NRI Range Over the Past 10 Years
Min: 11.28  Med: 16.4 Max: 22.59
Current: 19.93
11.28
22.59
Price-to-Owner-Earnings 18.14
UTMD's Price-to-Owner-Earnings is ranked higher than
79% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.93 vs. UTMD: 18.14 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
UTMD' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.65  Med: 14.97 Max: 20.4
Current: 18.14
8.65
20.4
PB Ratio 3.38
UTMD's PB Ratio is ranked higher than
52% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.56 vs. UTMD: 3.38 )
Ranked among companies with meaningful PB Ratio only.
UTMD' s PB Ratio Range Over the Past 10 Years
Min: 2.1  Med: 2.98 Max: 4.13
Current: 3.38
2.1
4.13
PS Ratio 6.31
UTMD's PS Ratio is ranked lower than
74% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.01 vs. UTMD: 6.31 )
Ranked among companies with meaningful PS Ratio only.
UTMD' s PS Ratio Range Over the Past 10 Years
Min: 2.56  Med: 4.27 Max: 6.97
Current: 6.31
2.56
6.97
Price-to-Free-Cash-Flow 21.85
UTMD's Price-to-Free-Cash-Flow is ranked higher than
74% of the 73 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.88 vs. UTMD: 21.85 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
UTMD' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.72  Med: 15.31 Max: 24.45
Current: 21.85
8.72
24.45
Price-to-Operating-Cash-Flow 16.87
UTMD's Price-to-Operating-Cash-Flow is ranked higher than
62% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.90 vs. UTMD: 16.87 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
UTMD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.52  Med: 14.16 Max: 18.86
Current: 16.87
8.52
18.86
EV-to-EBIT 12.78
UTMD's EV-to-EBIT is ranked higher than
84% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.30 vs. UTMD: 12.78 )
Ranked among companies with meaningful EV-to-EBIT only.
UTMD' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.3  Med: 10.1 Max: 15
Current: 12.78
5.3
15
EV-to-EBITDA 10.95
UTMD's EV-to-EBITDA is ranked higher than
79% of the 203 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.15 vs. UTMD: 10.95 )
Ranked among companies with meaningful EV-to-EBITDA only.
UTMD' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5  Med: 8.9 Max: 13.2
Current: 10.95
5
13.2
PEG Ratio 5.16
UTMD's PEG Ratio is ranked lower than
74% of the 58 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.65 vs. UTMD: 5.16 )
Ranked among companies with meaningful PEG Ratio only.
UTMD' s PEG Ratio Range Over the Past 10 Years
Min: 0.91  Med: 1.98 Max: 20.45
Current: 5.16
0.91
20.45
Shiller PE Ratio 24.93
UTMD's Shiller PE Ratio is ranked higher than
80% of the 45 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 43.41 vs. UTMD: 24.93 )
Ranked among companies with meaningful Shiller PE Ratio only.
UTMD' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.52  Med: 16.79 Max: 27.87
Current: 24.93
10.52
27.87
Current Ratio 7.55
UTMD's Current Ratio is ranked higher than
96% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.54 vs. UTMD: 7.55 )
Ranked among companies with meaningful Current Ratio only.
UTMD' s Current Ratio Range Over the Past 10 Years
Min: 1.6  Med: 4.43 Max: 14.9
Current: 7.55
1.6
14.9
Quick Ratio 6.66
UTMD's Quick Ratio is ranked higher than
96% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.67 vs. UTMD: 6.66 )
Ranked among companies with meaningful Quick Ratio only.
UTMD' s Quick Ratio Range Over the Past 10 Years
Min: 0.93  Med: 2.96 Max: 12.96
Current: 6.66
0.93
12.96
Days Inventory 107.34
UTMD's Days Inventory is ranked higher than
65% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.79 vs. UTMD: 107.34 )
Ranked among companies with meaningful Days Inventory only.
UTMD' s Days Inventory Range Over the Past 10 Years
Min: 88.85  Med: 101.24 Max: 107.34
Current: 107.34
88.85
107.34
Days Sales Outstanding 38.85
UTMD's Days Sales Outstanding is ranked higher than
93% of the 153 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.76 vs. UTMD: 38.85 )
Ranked among companies with meaningful Days Sales Outstanding only.
UTMD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 30.55  Med: 38.66 Max: 48.09
Current: 38.85
30.55
48.09
Days Payable 24.53
UTMD's Days Payable is ranked lower than
92% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.53 vs. UTMD: 24.53 )
Ranked among companies with meaningful Days Payable only.
UTMD' s Days Payable Range Over the Past 10 Years
Min: 10.38  Med: 16.11 Max: 24.53
Current: 24.53
10.38
24.53

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.59
UTMD's Dividend Yield % is ranked higher than
66% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. UTMD: 1.59 )
Ranked among companies with meaningful Dividend Yield % only.
UTMD' s Dividend Yield % Range Over the Past 10 Years
Min: 1.44  Med: 2.54 Max: 4.23
Current: 1.59
1.44
4.23
Dividend Payout Ratio 0.32
UTMD's Dividend Payout Ratio is ranked lower than
54% of the 85 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.30 vs. UTMD: 0.32 )
Ranked among companies with meaningful Dividend Payout Ratio only.
UTMD' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.32  Med: 0.39 Max: 0.54
Current: 0.32
0.32
0.54
3-Year Dividend Growth Rate 2.00
UTMD's 3-Year Dividend Growth Rate is ranked lower than
73% of the 64 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.60 vs. UTMD: 2.00 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
UTMD' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 25.3
Current: 2
0
25.3
Forward Dividend Yield % 1.60
UTMD's Forward Dividend Yield % is ranked higher than
62% of the 143 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.35 vs. UTMD: 1.60 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.76
UTMD's 5-Year Yield-on-Cost % is ranked lower than
51% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.87 vs. UTMD: 1.76 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
UTMD' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.59  Med: 2.8 Max: 4.67
Current: 1.76
1.59
4.67
3-Year Average Share Buyback Ratio 0.30
UTMD's 3-Year Average Share Buyback Ratio is ranked higher than
77% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.20 vs. UTMD: 0.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
UTMD' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -2.1  Med: 2.9 Max: 15.6
Current: 0.3
-2.1
15.6

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 11.61
UTMD's Price-to-Net-Cash is ranked higher than
62% of the 48 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.17 vs. UTMD: 11.61 )
Ranked among companies with meaningful Price-to-Net-Cash only.
UTMD' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 5.01  Med: 10.48 Max: 963
Current: 11.61
5.01
963
Price-to-Net-Current-Asset-Value 7.93
UTMD's Price-to-Net-Current-Asset-Value is ranked lower than
52% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.18 vs. UTMD: 7.93 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
UTMD' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 3.44  Med: 8.39 Max: 955
Current: 7.93
3.44
955
Price-to-Tangible-Book 5.99
UTMD's Price-to-Tangible-Book is ranked lower than
60% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.77 vs. UTMD: 5.99 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
UTMD' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.35  Med: 4.75 Max: 133.52
Current: 5.99
2.35
133.52
Price-to-Intrinsic-Value-Projected-FCF 1.37
UTMD's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
77% of the 82 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.03 vs. UTMD: 1.37 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
UTMD' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.48  Med: 0.9 Max: 9.09
Current: 1.37
0.48
9.09
Price-to-Median-PS-Value 1.48
UTMD's Price-to-Median-PS-Value is ranked lower than
67% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.14 vs. UTMD: 1.48 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
UTMD' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.29  Med: 0.82 Max: 1.64
Current: 1.48
0.29
1.64
Price-to-Graham-Number 2.30
UTMD's Price-to-Graham-Number is ranked higher than
56% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. UTMD: 2.30 )
Ranked among companies with meaningful Price-to-Graham-Number only.
UTMD' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.09  Med: 1.77 Max: 8.81
Current: 2.3
1.09
8.81
Earnings Yield (Greenblatt) % 7.82
UTMD's Earnings Yield (Greenblatt) % is ranked higher than
88% of the 267 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.18 vs. UTMD: 7.82 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
UTMD' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 6.7  Med: 9.9 Max: 19
Current: 7.82
6.7
19
Forward Rate of Return (Yacktman) % 7.20
UTMD's Forward Rate of Return (Yacktman) % is ranked lower than
58% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. UTMD: 7.20 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
UTMD' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 4  Med: 14 Max: 22.9
Current: 7.2
4
22.9

More Statistics

Revenue (TTM) (Mil) $39.26
EPS (TTM) $ 3.32
Beta0.61
Short Percentage of Float1.10%
52-Week Range $56.30 - 75.00
Shares Outstanding (Mil)3.72
» More Articles for UTMD

Headlines

Articles On GuruFocus.com
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2016 Apr 26 2016 
Charles Brandes Bets on Aaron's, Small-Cap ETF Feb 12 2016 
Utah Medical Products Reports Audited Financial Performance for Fourth Quarter and Year 2015 Feb 02 2016 
4 Top-Performing Healthcare Dividend Stocks with Single-Digit P/Es Jul 02 2013 
How to Screen for Hidden Champions Mar 23 2012 
10 High Margin Healthcare Dividend Shares Jan 02 2012 
Utah Medical Products, Inc: Stable Operator Rocks The Boat Sep 22 2011 
Utah Medical Products Inc. Reports Operating Results (10-Q) Nov 04 2010 
Utah Medical Products Inc. Reports Operating Results (10-Q) Aug 05 2010 
Utah Medical Products Inc. Dabbles in Stocks May 26 2010 

More From Other Websites
Utah Medical Products, Inc. Announces Quarterly Dividend May 09 2017
Utah Medical posts 1Q profit Apr 25 2017
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2017 Apr 25 2017
Utah Medical Products, Inc. : UTMD-US: Dividend Analysis : March 17th, 2017 (record date) : By the... Apr 06 2017
Utah Medical Products, Inc. :UTMD-US: Earnings Analysis: Q4, 2016 By the Numbers : March 13, 2017 Mar 13 2017
Utah Medical Products, Inc. : UTMD-US: Dividend Analysis : December 16th, 2016 (record date) : By... Feb 01 2017
UTMD Reports Audited Financial Performance for Fourth Quarter and Year 2016 Jan 31 2017
Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2016 Oct 25 2016
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2016 Jul 26 2016
Utah Medical Products Reports Audited Financial Performance for Fourth Quarter and Year 2015 Feb 02 2016
Is Xerium Technologies, Inc. (XRM) A Good Stock To Buy? Dec 11 2015
Hedge Funds Aren’t Crazy About Utah Medical Products, Inc. (UTMD) Anymore Nov 25 2015
Utah Medical Products, Inc. Earnings Q3, 2015 Nov 10 2015
Utah Medical Products, Inc. Increases Quarterly Dividend Nov 03 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)